FDA Inspection 735153 — Sigma-Tau Pharmaceuticals, Inc.

Sigma-Tau Pharmaceuticals, Inc. — FEI 2245635

The FDA completed an inspection of Sigma-Tau Pharmaceuticals, Inc. on Jul 18, 2011 in Gaithersburg, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jul 18, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Gaithersburg, MD (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)